Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis.

Fady T Botros Ulagamadesan VenkatesanRaleigh MalikClaudia NicolayAnastasia HooverIbrahim TurfandaHelen Martina ColhounJonathan E Shaw

Published in: Diabetes care (2023)

The estimated 25% reduced hazard of a kidney function-related outcome among participants assigned to DU highlights its potential for delaying or slowing the development of diabetic kidney disease in people with type 2 diabetes.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
metabolic syndrome
weight loss